GlassScriptPhysician profile
Marta S Johnson-Mitchell
NPI 1356570055
$2,522.52
in general payments reported to CMS, 2019-2025
27 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $191 · 2021: $254 · 2022: $1,023 · 2023: $281 · 2024: $256 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $714.90 | 2022 | |
| Astellas Pharma US INC | $248.23 | 2019-2024 | Myrbetriq |
| Abbvie INC. | $205.28 | 2020-2025 | |
| Boston Scientific Corporation | $204.35 | 2020-2025 | Rezum Generator, Upsylon |
| Allergan, INC. | $197.67 | 2019-2020 | |
| Coloplast Corp | $151.64 | 2021-2023 | Titan |
| Myriad Genetic Laboratories, INC. | $97.65 | 2021-2025 | Myrisk |
| Dendreon Pharmaceuticals LLC | $93.73 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $91.37 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $82.70 | 2022 | |
| Pfizer INC. | $57.59 | 2019-2021 | |
| Axonics, INC. | $51.47 | 2020-2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $44.83 | 2020-2024 | |
| C. R. Bard, INC. & Subsidiaries | $35.91 | 2024 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $33.18 | 2025 | Xiaflex |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $26.83 | 2023 | Soltive, Dornier Thulio |
| Tolmar, INC. | $25.32 | 2025 | Jatenzo, Eligard |
| Innovation Technologies INC | $20.78 | 2023 | Irrisept |
| Braintree Laboratories, INC. | $19.89 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.56 | 2019 | |
| Endo Pharmaceuticals INC. | $18.36 | 2021 | |
| Accord Healthcare, INC. | $17.15 | 2024 | |
| Laborie Medical Technologies Corp. | $17.10 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Cook Medical LLC | $16.36 | 2024 | Cook |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $11.95 | 2022 | |
| Procept Biorobotics Corporation | $7.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marta Johnson-Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.